Home › NDC Lookup › RxCUI directory › RxCUI 352228

Ziprasidone 20 MG Injection [Geodon] — RxCUI 352228

RxNorm drug concept · Semantic branded drug
RxCUI 352228 Semantic branded drug · SBD ● Current RxNorm concept 12 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI352228
Official nameZiprasidone 20 MG Injection [Geodon]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asGeodon 20 MG Injection; Geodon (as ziprasidone mesylate) 20 MG Injection
FDA products mapped12
Package NDCs mapped9
Reported Medicaid activity (SDUD)158 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ziprasidone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Geodon for injection is specifically used to rapidly calm severe agitation in adults who have schizophrenia. It's given as a shot into the muscle by a healthcare professional — not...
  • What exactly is Geodon injection used for?
  • They contain the same active ingredient — ziprasidone — but they're not interchangeable. The injection is only approved for acute agitation in schizophrenia and is given by a healt...
  • Is the injection the same as the Geodon capsules?
📖 Read our full Ziprasidone Injection guide →

🕸️ Concept Web — How Ziprasidone 20 MG Injection [Geodon] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ziprasidone 20 MG Injection [Geodon] RxCUI 352228

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ziprasidone 115698
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Geodon 285064
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ziprasidone Injection 1727275
    • Ziprasidone Injectable Product 1156248
    • Ziprasidone Injection [Geodon] 1727277
    • Geodon Injectable Product 1170504
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ziprasidone 20 MG Injection SCD · 351223
  • Ziprasidone 20 MG SCDC · 330414
  • Ziprasidone Injection SCDF · 1727275
  • Ziprasidone Injectable Product SCDG · 1156248

Brand-Name Concepts

  • Ziprasidone 20 MG [Geodon] SBDC · 575092
  • Ziprasidone Injection [Geodon] SBDF · 1727277
  • Geodon Injectable Product SBDG · 1170504
  • Geodon BN · 285064

📦 FDA Products & Package NDCs

12 products · 9 package NDCs
9 package NDCs map to RxCUI 352228 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00049-0056-60 60 CAPSULE in 1 BOTTLE (0049-0056-60) Geodon ROERIG 2019-08-01
00049-0058-60 60 CAPSULE in 1 BOTTLE (0049-0058-60) Geodon ROERIG 2019-08-01
00049-0352-60 60 CAPSULE in 1 BOTTLE (0049-0352-60) Geodon ROERIG 2021-11-08
00049-0354-60 60 CAPSULE in 1 BOTTLE (0049-0354-60) Geodon ROERIG 2023-07-14
00049-0356-60 60 CAPSULE in 1 BOTTLE (0049-0356-60) Geodon ROERIG 2021-11-08
00049-0358-60 60 CAPSULE in 1 BOTTLE (0049-0358-60) Geodon ROERIG 2021-11-08
00049-3920-10 10 VIAL, SINGLE-DOSE in 1 CARTON (0049-3920-10) / 1 mL in 1... Geodon ROERIG 2024-07-24
58151-0134-91 60 CAPSULE in 1 BOTTLE (58151-134-91) Geodon Viatris Specialty LLC 2026-04-15
58151-0137-81 10 VIAL in 1 CARTON (58151-137-81) / 1 mL in 1 VIAL Geodon Viatris Specialty LLC 2025-09-09
Observed labelers: ROERIG (7) · Viatris Specialty LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J3486 Ziprasidone mesylate 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.